MicroRNA-cancer connection: the beginning of a new tale.
By George A. Calin, Carlo Maria Croce. Cancer Research, 2006
1,075 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/47b3fae370d488eb91f75293f105d1939e1f6c85
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Carlo Maria Croce
- George A. Calin
- Heidi J. Peltier
- G. Latham
- Ç. Gerçel-Taylor
- D. Taylor
- S. Alahari
- S. Shenouda
In Molecular Biology
- Carlo Maria Croce
- George A. Calin
- Heidi J. Peltier
- G. Latham
- Ç. Gerçel-Taylor
- D. Taylor
- S. Alahari
- S. Shenouda
Citations in the corpus
- MicroRNA signatures in human cancers (2006, background): “In a specific tumour, abnormalities both in protein-coding genes and miRNAs can be identifie”
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. (2008, background): “All tumors analyzed by microRNA profiling have exhibited significantly distinct microRNA signatures, compared with normal cells from the same tissue [4,6,10].”
- miR2Disease: a manually curated database for microRNA deregulation in human disease (2008, background): “First, microRNAs are located in the diseasecausing genomic loci, including minimal regions of loss of heterozygosity, minimal amplicon, or breakpoint cluster regions (19,25).”
- MicroRNAs — the micro steering wheel of tumour metastases (2009, background): “Recent studies show that miRNAs may be members of the still elusive class of cancer-predisposing genes and that other types of ncRNAs also participate in the genetic puzzle giving rise to the malignant phenotype (for reviews see Ref”
- MicroRNA signature predicts survival and relapse in lung cancer. (2008, methodology): “MicroRNAs can posttranscriptionally regulate the expression of hundreds of their target genes, thereby controlling a wide range of biological functions such as cellular proliferation, differentiation, and apoptosis (Calin and Croce, 2006b).”
- Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. (2008, background): “It has been suggested that the capability of miRNAs to regulate multiple targets within the same pathway can amplify their biological effects (Calin and Croce 2006b).”
- MicroRNA function in cancer: oncogene or a tumor suppressor? (2009, background): “Furthermore, the let-7 family members that target RAS oncogenes in lung cancer, like miR-15a and miR 16-1, which target BCL2 oncogene in chronic lymphocytic leukemia, contribute to oncogenesis by functioning as down-regulated tumor suppressors [54].”
- Characterization of a germ-line deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. (2007, background): “Moreover, we cannot rule out the possibility that ANRIL gene could be able to produce mature miRNAs (19) or encode a small peptide (20).”